Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Apr 9, 2019 at 10:05 AM EDT

Bad News for Epilepsy Seizure Patients Following FDA Update

Zogenix shares were crushed on Tuesday after the firm provided an update from the FDA regarding Fintepla for the treatment…

Chris Lange | Apr 9, 2019 at 9:05 AM EDT

What’s Next for PhaseBio’s Antiplatelet Reversal Agent

PhaseBio shares made a sizeble gain on Tuesday morning after the FDA provided a critical update for the firm.

Chris Lange | Apr 8, 2019 at 11:10 AM EDT

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Alnylam Pharma and Regeneron Pharma shares dipped on Monday despite announcing a collaboration to discover, develop and commercialize new RNA…

Chris Lange | Apr 8, 2019 at 10:05 AM EDT

High Hopes for This Neulasta Biosimiliar for Cancer Treatment

Coherus BioSciences shares jumped on Monday morning after the firm released updated sales for its first quarter.

Chris Lange | Apr 5, 2019 at 9:20 AM EDT

Merrimack Discontinues Cancer Study Amidst Layoffs

Merrimack Pharmaceuticals shares dipped on Friday after the firm announced that it would be discontinuing one of its cancer drugs…

Paul Ausick | Apr 4, 2019 at 12:20 PM EDT

Do E-Cigarettes Cause Seizures in Young Users?

The FDA has issued a safety alert related to the use of e-cigarettes, especially among young Americans. The agency has…

Chris Lange | Apr 4, 2019 at 10:40 AM EDT

PTSD Treatment Looked at for Fibromyalgia

Tonix Pharmaceuticals shares jumped on Monday after the firm announced the expansion of its late-stage PTSD treatment.

Chris Lange | Apr 3, 2019 at 11:10 AM EDT

Drug Candidate Makes Big Strides in the Treatment of Parkinson’s Disease Cognitive Impairment

Aptinyx has announced positive preclinical data on its drug candidate demonstrating reversal of cognitive deficits in a nonhuman primate model…

Chris Lange | Apr 3, 2019 at 10:25 AM EDT

The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer

Agricultural engineering firm Evogene has announced the establishment of a new subsidiary to develop next-generation medical cannabis products.

Paul Ausick | Apr 2, 2019 at 2:18 PM EDT

Opioid Prescriptions Are Down, So Why Are They Still Killing Americans?

A new study on prescription opioid use in the United States finds that while dosages and amounts are dropping, longer-term…

Chris Lange | Apr 2, 2019 at 11:40 AM EDT

What’s Next for Sangamo After This Hemophilia Study

Sangamo Therapeutics shares jumped on Tuesday after the company announced interim data from its midstage hemophilia trial in collaboration with…

Chris Lange | Apr 2, 2019 at 10:45 AM EDT

How Apyx Medical Was Crushed by the FDA

Apyx Medical shares dropped sharply on Tuesday after the company announced that it has voluntarily withdrawn its application for premarket…

Douglas A. McIntyre | Apr 2, 2019 at 6:20 AM EDT

Americans Borrowed $88 Billion for Health Care Last Year

Health care costs in the United States are generally measured as the highest in the world. Last year, many Americans…

Chris Lange | Mar 28, 2019 at 12:25 PM EDT

What’s Next for Tricida’s Chronic Kidney Disease Treatment

Tricida shares jumped on Thursday after the firm announced results from its chronic kidney disease study.

Chris Lange | Mar 28, 2019 at 11:10 AM EDT

Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?

Proteon Therapeutics shares were absolutely crushed on Thursday after the firm announced results from its late-stage trial in patients with…

1 … 101 102 103 104 105 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Bad News for Epilepsy Seizure Patients Following FDA Update

What’s Next for PhaseBio’s Antiplatelet Reversal Agent

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

High Hopes for This Neulasta Biosimiliar for Cancer Treatment

Merrimack Discontinues Cancer Study Amidst Layoffs

Do E-Cigarettes Cause Seizures in Young Users?

PTSD Treatment Looked at for Fibromyalgia

Drug Candidate Makes Big Strides in the Treatment of Parkinson’s Disease Cognitive Impairment

The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer

Opioid Prescriptions Are Down, So Why Are They Still Killing Americans?

What’s Next for Sangamo After This Hemophilia Study

How Apyx Medical Was Crushed by the FDA

Americans Borrowed $88 Billion for Health Care Last Year

What’s Next for Tricida’s Chronic Kidney Disease Treatment

Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?

XSD Delivers 1,138% in Ten Years, Yet Trails SOXX in the AI Boom

Warren Buffett Owns 2 of the Small Dogs of the Dow: Here’s Why You Need to Own All 5

XRP Price Prediction: XRP Breaks Above $1.40 — Can It Hit $1.45 Next?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

XSD Delivers 1,138% in Ten Years, Yet Trails SOXX in the AI Boom

Warren Buffett Owns 2 of the Small Dogs of the Dow: Here’s Why You Need to Own All 5

Health and Healthcare Articles

All Health and Healthcare Articles

Bad News for Epilepsy Seizure Patients Following FDA Update

What’s Next for PhaseBio’s Antiplatelet Reversal Agent

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

High Hopes for This Neulasta Biosimiliar for Cancer Treatment

Merrimack Discontinues Cancer Study Amidst Layoffs

Do E-Cigarettes Cause Seizures in Young Users?

PTSD Treatment Looked at for Fibromyalgia

Drug Candidate Makes Big Strides in the Treatment of Parkinson’s Disease Cognitive Impairment

The Search for Next-Generation Medical Cannabis for PTSD, Chronic Pain and Cancer

Opioid Prescriptions Are Down, So Why Are They Still Killing Americans?

What’s Next for Sangamo After This Hemophilia Study

How Apyx Medical Was Crushed by the FDA

Americans Borrowed $88 Billion for Health Care Last Year

What’s Next for Tricida’s Chronic Kidney Disease Treatment

Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?

XSD Delivers 1,138% in Ten Years, Yet Trails SOXX in the AI Boom

Warren Buffett Owns 2 of the Small Dogs of the Dow: Here’s Why You Need to Own All 5

XRP Price Prediction: XRP Breaks Above $1.40 — Can It Hit $1.45 Next?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up